Literature DB >> 31208713

A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies.

Alexander Kalinkovich1, Gregory Livshits2.   

Abstract

BACKGROUND: Emerging evidence suggests that dysbiosis, imbalanced gut microbial community, might be a key player in the development of various diseases, including inflammatory arthropathies, such as rheumatoid arthritis, spondyloarthritis (mainly, ankylosing spondylitis and psoriatic arthritis), and osteoarthritis. Yet, the underlying mechanisms and corresponding interactions remain poorly understood.
METHODS: We conducted a critical and extensive literature review to explore the association between dysbiosis and the development of inflammatory arthropathies. We also reviewed the literature to assess the perspectives that ameliorate inflammatory arthropathies by manipulating the microbiota with probiotics, prebiotics or fecal microbiota transplantation.
RESULTS: Some bacterial species (e.g. Prevotella, Citrobacter rodentium, Collinsella aerofaciens, Segmented filamentous bacteria) participate in the creation of the pro-inflammatory immune status, presumably via epitope mimicry, modification of self-antigens, enhanced cell apoptosis mechanisms, and destruction of tight junction proteins and intestinal barrier integrity, all leading to the development and maintainance of inflammatory arthropathies. Whether dysbiosis is an epiphenomenon or is an active driver of these disorders remains unclear, yet, recent observations clearly suggest that dysbiosis precedes and triggers their development implying a causative relationship between dysbiosis and inflammatory arthropathies. The underlying mechanisms include dysbiosis-mediated changes in the functional activity of the intestinal immune cell subsets, such as innate lymphoid cells, mucosa-associated invariant T cells, invariant natural killer T cells, T-follicular helper and T-regulatory cells. In turn, disturbed functionality of the gut-associated immune system is shown to promote the overgrowth of many bacteria, thus establishing a detrimental vicious circle of actively maintaining arthritis.
CONCLUSIONS: Analysis of the data described in the review supports the notion that a close, dynamic and tightly regulated cross talk between dysbiosis and the gut-associated immune system governs the development of inflammatory arthropathies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dysbiosis; Gut; Inflammation; Osteoarthritis; Rheumatoid arthritis; Spondyloarthritis

Year:  2019        PMID: 31208713     DOI: 10.1016/j.semarthrit.2019.05.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  16 in total

1.  Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis.

Authors:  Fangze Zhang; Cuili Ma; Bin Zhang; Liqi Bi
Journal:  Clin Rheumatol       Date:  2020-03-26       Impact factor: 2.980

2.  Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments.

Authors:  Gurjit S Kaeley; Jaspreet K Kaler
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

3.  Lactobacillus acidophilus Mitigates Osteoarthritis-Associated Pain, Cartilage Disintegration and Gut Microbiota Dysbiosis in an Experimental Murine OA Model.

Authors:  InSug O-Sullivan; Arivarasu Natarajan Anbazhagan; Gurjit Singh; Kaige Ma; Stefan J Green; Megha Singhal; Jun Wang; Anoop Kumar; Pradeep K Dudeja; Terry G Unterman; Gina Votta-Velis; Benjamin Bruce; Andre J van Wijnen; Hee-Jeong Im
Journal:  Biomedicines       Date:  2022-06-01

Review 4.  Iron Supplementation at the Crossroads of Nutrition and Gut Microbiota: The State of the Art.

Authors:  Ana M Puga; María de Lourdes Samaniego-Vaesken; Ana Montero-Bravo; Mar Ruperto; Teresa Partearroyo; Gregorio Varela-Moreiras
Journal:  Nutrients       Date:  2022-05-04       Impact factor: 6.706

5.  The influence of blood on the human gut microbiome.

Authors:  Thierry Chénard; Mandy Malick; Jean Dubé; Eric Massé
Journal:  BMC Microbiol       Date:  2020-03-03       Impact factor: 3.605

Review 6.  The innate immune perspective of autoimmune and autoinflammatory conditions.

Authors:  Shirly Frizinsky; Soad Haj-Yahia; Diti Machnes Maayan; Yulia Lifshitz; Ramit Maoz-Segal; Irean Offengenden; Mona Kidon; Nancy Agmon-Levin
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

Review 7.  Microbes, helminths, and rheumatic diseases.

Authors:  Francisco Airton Castro Rocha; Ana Margarida Duarte-Monteiro; Licia Maria Henrique da Mota; Ana Carolina Matias Dinelly Pinto; João Eurico Fonseca
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-05-07       Impact factor: 4.098

8.  Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice.

Authors:  Ling-Ling Jia; Ming Zhang; He Liu; Jia Sun; Li-Long Pan
Journal:  Acta Pharmacol Sin       Date:  2021-01-20       Impact factor: 7.169

Review 9.  Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.

Authors:  Huihui Xu; Hongyan Zhao; Danping Fan; Meijie Liu; Jinfeng Cao; Ya Xia; Dahong Ju; Cheng Xiao; Qingdong Guan
Journal:  Mediators Inflamm       Date:  2020-09-09       Impact factor: 4.711

Review 10.  Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases.

Authors:  Priyanka Jadhav; Yan Jiang; Karolin Jarr; Cosima Layton; Judith F Ashouri; Sidhartha R Sinha
Journal:  Nutrients       Date:  2020-07-20       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.